- Seres Therapeutics to Present at the Barclays Global Healthcare Conference
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (NASDAQ:MCRB), a leading microbiome therapeutics platform company, today announced it will present at the Barclays Global Healthcare Conference on Thursday, March 17.
- Seres Therapeutics Inc (NASDAQ:MCRB) Given Consensus Recommendation of "Buy
- Seres Therapeutics logo Seres Therapeutics Inc (NASDAQ:MCRB) has been assigned an average rating of “Buy” from the seven brokerages that are presently covering the firm, Analyst Ratings Net reports. One investment analyst has rated the stock with a ...
- Stock Update & Price Target on Seres Therapeutics Inc (NASDAQ:MCRB)
- Seres Therapeutics Inc (NASDAQ:MCRB) shares traded +1.74% during the most recent session. Wall Street analysts covering the stock are projecting that the stock will reach $44.
- Seres Are Spanish-Singing, Latex-Wearing Misfits from Another Time and Place
- Imagine Devo, sung in Spanish and played at 78 rpm, and you have a rough idea of what Seres sounds like. Waiting at Exposition Circle, the three men are standing between the columns of the memorial, which almost resembles Stonehenge. They are ...
- AMC Greenlights Scott Free Anthology Series 'The Terror'
- AMC has greenlighted the new 10-part anthology drama series “The Terror,” an adaptation of Dan Simmons' best-selling novel. Scott Free, Emjag Productions and Entertainment 360 will produce the hour-long drama, in association with AMC Studios.
Seres is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Seres books and related discussion.